Design, synthesis and anticancer activities of hybrids of indole and barbituric acids—Identification of highly promising leads

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

By combining the structural features of indole and barbituric acid, new hybrid molecules were designed and synthesized. Evaluations of these molecules over 60 cell line panel of human cancer cells have identified two molecules with significant anticancer activities. Dockings of two active molecules in the active sites of COX-2, thymidylate synthase and ribonucleotide reductase indicate their strong interactions with these enzymes.

Knowledge Graph

Similar Paper

Design, synthesis and anticancer activities of hybrids of indole and barbituric acids—Identification of highly promising leads
Bioorganic & Medicinal Chemistry Letters 2009.0
Design and Synthesis of Novel β‐Carboline‐Bisindole Hybrids as Potential Anticancer Agents
ChemMedChem 2024.0
Rationally designed hybrid molecules with appreciable COX-2 inhibitory and anti-nociceptive activities
Bioorganic & Medicinal Chemistry Letters 2014.0
1-Toluene-sulfonyl-3-[(3′-hydroxy-5′-substituted)-γ-butyrolactone]-indoles: Synthesis, COX-2 inhibition and anti-cancer activities
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthetic methodology-enabled discovery of a tunable indole template for COX-1 inhibition and anti-cancer activity
Bioorganic & Medicinal Chemistry 2022.0
Multisubstituted indole–acrylonitrile hybrids as potential cytotoxic agents
Bioorganic & Medicinal Chemistry Letters 2014.0
Design and synthesis of novel phenyl -1, 4-beta-carboline-hybrid molecules as potential anticancer agents
European Journal of Medicinal Chemistry 2017.0
Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities
European Journal of Medicinal Chemistry 2014.0
Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents
European Journal of Medicinal Chemistry 2014.0